Items where authors include "Peel, N."

Article

Mattia, L., Davis, S. orcid.org/0000-0002-6609-4287, Mark-Wagstaff, C. et al. (4 more authors) (2022) Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation). Bone, 158. 116347. ISSN 8756-3282

Schini, M. orcid.org/0000-0003-2204-2095, Peel, N., Toronjo-Urquiza, L. et al. (5 more authors) (2022) Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis. Osteoporosis International, 33 (3). pp. 737-744. ISSN 0937-941X

Harvey, N.C., Poole, K.E., Ralston, S.H. et al. (47 more authors) (2022) Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Archives of Osteoporosis, 17 (1). 12. ISSN 1862-3522

Schini, M. orcid.org/0000-0003-2204-2095, Jacques, R. orcid.org/0000-0001-6710-5403, Oakes, E. et al. (3 more authors) (2021) Normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT): Least significant change (LSC) for adjusted serum calcium. European Journal of Endocrinology, 184 (1). K7-K10. ISSN 0804-4643

Paggiosi, M.A. orcid.org/0000-0002-1030-0723, Peel, N., McCloskey, E. orcid.org/0000-0003-0177-8140 et al. (2 more authors) (2020) Comparison of treatment responder rates for three oral bisphosphonates: the TRIO study. Bone Reports, 13. 100677. ISSN 2352-1872

Schini, M. orcid.org/0000-0003-2204-2095, Stirling, R., Jacques, R. orcid.org/0000-0001-6710-5403 et al. (4 more authors) (2020) The prevalence and natural history of normocalcaemic hypoparathyroidism in a United Kingdom referral population. Clinical Endocrinology, 93 (2). pp. 119-126. ISSN 0300-0664

Schini, M. orcid.org/0000-0003-2204-2095, Jacques, R. orcid.org/0000-0001-6710-5403, Oakes, E. et al. (3 more authors) (2020) Normocalcemic hyperparathyroidism : study of its prevalence and natural history. The Journal of Clinical Endocrinology & Metabolism, 105 (4). dgaa084. ISSN 0021-972X

Gossiel, F., Paggiosi, M.A. orcid.org/0000-0002-1030-0723, Naylor, K.E. et al. (4 more authors) (2020) The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. Bone, 131. 115158. ISSN 8756-3282

Adami, G., Saag, K.G., Chapurlat, R.D. et al. (7 more authors) (2019) Balancing benefits and risks in the era of biologics. Therapeutic Advances in Musculoskeletal Disease, 11. ISSN 1759-720X

Paggiosi, M.A. orcid.org/0000-0002-1030-0723, Yang, L., Blackwell, D. et al. (4 more authors) (2018) Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study. Osteoporosis International, 29 (6). pp. 1367-1378. ISSN 0937-941X

Gossiel, F., Hoyle, C., McCloskey, E.V. et al. (4 more authors) (2016) The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. Bone, 92. pp. 94-99. ISSN 8756-3282

Proceedings Paper

Schini, M. orcid.org/0000-0003-2204-2095, Peel, N., Toronjo-Urquiza, L. et al. (5 more authors) (2022) 1060: Renal safety of zoledronic acid in patients with borderline kidney function at a metabolic bone centre In the United Kingdom. In: Journal of Bone and Mineral Research. ASBMR Annual Meeting 2021, 01-04 Oct 2021, San Diego, California. Wiley , S271-S271.

Paggiosi, M.A., Yang, L., Blackwell, D. et al. (4 more authors) (2016) Response to Teriparatide Treatment Differs by Anatomical Site and Bone Compartment. In: Osteoporosis International. Osteoporosis Conference 2016, 07-09 Nov 2016, Birmingham, UK. Springer , S621-S622.

Gossiel, F., McCloskey, E. orcid.org/0000-0003-0177-8140, Walsh, J. orcid.org/0000-0002-7122-2650 et al. (3 more authors) (2016) OC3.4: The response of fibroblast growth factor-23 to teriparatide in postmenopausal osteoporosis. In: Bone Abstracts. 43rd Annual European Calcified Tissue Society Congress, 14-17 May 2016, Rome, Italy. Bioscientifica .